Danaher (DHR)
(Delayed Data from NYSE)
$239.60 USD
-3.65 (-1.50%)
Updated Nov 12, 2024 04:00 PM ET
After-Market: $239.58 -0.02 (-0.01%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth B Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$239.60 USD
-3.65 (-1.50%)
Updated Nov 12, 2024 04:00 PM ET
After-Market: $239.58 -0.02 (-0.01%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth B Momentum F VGM
Zacks News
Should You Invest in the Invesco Global Water ETF (PIO)?
by Zacks Equity Research
Sector ETF report for PIO
HTHIY or DHR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
HTHIY vs. DHR: Which Stock Is the Better Value Option?
Catalent (CTLT) Surges on Rumors of Acquisition by Danaher
by Zacks Equity Research
Catalent (CTLT) shares gain significantly, following a Bloomberg report about a potential acquisition of the CDMO company by Danaher, a life sciences company.
Danaher (DHR) Q4 Earnings & Revenues Beat, Increase Y/Y
by Zacks Equity Research
Danaher's (DHR) Q4 results benefit from strong segmental performances and organic sales growth.
Danaher (DHR) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Danaher (DHR) delivered earnings and revenue surprises of 16.67% and 9.58%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
HTHIY vs. DHR: Which Stock Is the Better Value Option?
by Zacks Equity Research
HTHIY vs. DHR: Which Stock Is the Better Value Option?
Danaher (DHR) Stock Moves -1.56%: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $270.62, moving -1.56% from the previous trading session.
Will Cost Headwinds Dampen Danaher's (DHR) Q4 Earnings?
by Zacks Equity Research
High raw material costs and supply-chain disruptions are likely to have hurt Danaher's (DHR) Q4 earnings. However, the top line is likely to have benefited from an expected increase in revenues at the Environmental & Applied Solutions segment.
Analysts Estimate Danaher (DHR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Danaher (DHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Hold Strategy is Apt for Danaher (DHR) Stock Now
by Zacks Equity Research
Strength across the Life Sciences segment, inorganic activities and DBS initiatives bode well for Danaher's (DHR) growth. Shareholder-friendly policies add to the stock's appeal.
Danaher (DHR) Provides Improved Q4 Core Revenue Growth Guidance
by Zacks Equity Research
Benefiting from strong growth in Cepheid's molecular diagnostics among other factors, Danaher (DHR) improves its adjusted core revenue growth guidance for the fourth quarter of 2022.
Danaher (DHR) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $255.05, moving +1.01% from the previous trading session.
Danaher (DHR) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Danaher (DHR) closed at $262.27, marking a -1.19% move from the previous day.
Why Danaher (DHR) Could Beat Earnings Estimates Again
by Zacks Equity Research
Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
How to Find Strong Multi-Sector Conglomerates Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Danaher (DHR) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $260.88, moving +0.39% from the previous trading session.
Top Analyst Reports for AbbVie, PepsiCo & Oracle
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), PepsiCo, Inc. (PEP) and Oracle Corporation (ORCL).
Danaher (DHR) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $255.60, moving -1.21% from the previous trading session.
Danaher (DHR) Up 14% in 6 Months: What's Driving the Stock?
by Zacks Equity Research
Danaher (DHR) gains from strength across its core Life Sciences segment, benefits from the DBS initiatives and acquired assets. The company's efforts to add shareholder value hold promise.
Danaher (DHR) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Danaher (DHR) closed at $274.23, marking a -0.89% move from the previous day.
Danaher (DHR) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $271.82, moving +1.33% from the previous trading session.
Danaher (DHR) Stock Moves -0.11%: What You Should Know
by Zacks Equity Research
In the latest trading session, Danaher (DHR) closed at $274.23, marking a -0.11% move from the previous day.
GE (GE) Up 16.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
GE (GE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Danaher (DHR) Just Reclaimed the 200-Day Moving Average
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 200-day simple moving average. How should investors react?
Here's How Much a $1000 Investment in Danaher Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.